Abbott India Ltd. reported its financial results for the second quarter of FY25, showing strong growth in both revenue and net profit compared to the same period last year.
Financial Highlights
- Revenue from Operations: Abbott India reported revenue from operations of ₹1,632.67 crore for Q2 FY25, reflecting a 9.3% increase from ₹1,494.14 crore in Q2 FY24. Quarter-over-quarter (QoQ), revenue rose by 4.8% from ₹1,557.61 crore in Q1 FY25.
- Profit Before Tax (PBT): The PBT for Q2 FY25 stood at ₹479.43 crore, marking a 15.4% YoY increase from ₹415.42 crore in Q2 FY24. QoQ, PBT rose by 9.6% from ₹437.22 crore in Q1 FY25.
- Net Profit: Abbott India’s net profit for Q2 FY25 was ₹358.61 crore, up 14.6% YoY from ₹312.94 crore in Q2 FY24. On a QoQ basis, net profit increased by 9.3% from ₹328.01 crore in Q1 FY25.
The positive YoY and QoQ growth in Abbott India’s financials demonstrates the company’s resilience and effective strategies to drive revenue and profitability.
Summary
Abbott India has delivered strong financial results in Q2 FY25, with solid increases in both revenue and profit. The company’s consistent performance highlights its robust market position in the healthcare sector and its ability to adapt to evolving market dynamics.
TOPICS:
Abbott India